Product image of Alprolix (Eftrenonacog Alfa) supplied by GNH India

Alprolix

Active Ingredient:
Eftrenonacog Alfa
Origin:
EU

Alprolix (Eftrenonacog Alfa)

Alprolix (Eftrenonacog Alfa) is a recombinant coagulation factor IX used for hemophilia B treatment. This intravenous medication helps manage bleeding episodes and prevent complications.

Manufacturer / TM Owner

Swedish Orphan Biovitrum Ab (Publ)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Alprolix is primarily used for the control and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. It is designed to replace the missing clotting factor IX, which is essential for normal blood coagulation. This medication is often used as part of a comprehensive treatment plan for individuals with hemophilia B, helping to manage symptoms and improve quality of life.

Side Effects

  • Common effects of Alprolix may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some users may experience mild to moderate headaches or joint pain. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Precautions & Warnings

  • Alprolix should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed guidelines for intravenous use and to monitor for any signs of allergic reactions. Patients should inform their healthcare provider about any pre-existing conditions or medications they are taking before starting treatment with Alprolix.

Avoid Interactions

  • Alprolix may interact with certain medications, particularly those that affect blood clotting. It is advisable to consult with a healthcare provider before combining Alprolix with other treatments. Additionally, patients should be cautious when using Alprolix alongside anticoagulants or antiplatelet drugs, as these can influence its effectiveness.

Frequently Asked Questions

Alprolix is used to manage and prevent bleeding episodes in patients with hemophilia B, a condition characterized by a deficiency in clotting factor IX.

Alprolix is administered intravenously, typically by a healthcare professional, to ensure proper dosage and administration.

Common side effects may include localized reactions at the injection site, headaches, and joint pain. These effects are usually temporary.

Patients should consult their healthcare provider before combining Alprolix with other medications, especially those that affect blood clotting.

Alprolix is manufactured by Swedish Orphan Biovitrum Ab (Publ), a company based in the EU.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Eftrenonacog Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT